Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
XENE holding history
Xenon Pharmaceuticals Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XENE overviewAll 13F holders of XENEFull Q1 2025 holdings
- Shares (Q1 2025)
- 198
- Value
- $6.64K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 198 | $6.64K | <0.1% | −27−12.0% | Reduced | Holders |
| Q4 2024 | 225 | $8.82K | <0.1% | −4−1.7% | Reduced | Holders |
| Q3 2024 | 229 | $9.02K | <0.1% | −94−29.1% | Reduced | Holders |
| Q2 2024 | 323 | $12.6K | <0.1% | +320+10,666.7% | Added | Holders |
| Q1 2024 | 3 | $129 | <0.1% | +3 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −14−100.0% | Sold out | Holders |
| Q3 2023 | 14 | $478 | <0.1% | +14 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q3 2021 | 1,000 | $15.0K | <0.1% | +1,000 | New | Holders |